Logo image of MRAM

EVERSPIN TECHNOLOGIES INC (MRAM) Stock Fundamental Analysis

USA - NASDAQ:MRAM - US30041T1043 - Common Stock

9.85 USD
-0.61 (-5.83%)
Last: 11/4/2025, 8:00:02 PM
9.85 USD
0 (0%)
Pre-Market: 11/5/2025, 7:49:11 AM
Fundamental Rating

5

MRAM gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 112 industry peers in the Semiconductors & Semiconductor Equipment industry. No worries on liquidiy or solvency for MRAM as it has an excellent financial health rating, but there are worries on the profitability. MRAM is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year MRAM was profitable.
MRAM had a positive operating cash flow in the past year.
MRAM had positive earnings in 4 of the past 5 years.
Of the past 5 years MRAM 4 years had a positive operating cash flow.
MRAM Yearly Net Income VS EBIT VS OCF VS FCFMRAM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

1.2 Ratios

With a Return On Assets value of 2.09%, MRAM perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
Looking at the Return On Equity, with a value of 2.57%, MRAM is in line with its industry, outperforming 56.25% of the companies in the same industry.
Industry RankSector Rank
ROA 2.09%
ROE 2.57%
ROIC N/A
ROA(3y)8.51%
ROA(5y)2.08%
ROE(3y)11.3%
ROE(5y)0.19%
ROIC(3y)N/A
ROIC(5y)N/A
MRAM Yearly ROA, ROE, ROICMRAM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600 -800

1.3 Margins

The Profit Margin of MRAM (3.19%) is comparable to the rest of the industry.
MRAM's Profit Margin has declined in the last couple of years.
MRAM has a better Gross Margin (50.84%) than 65.18% of its industry peers.
MRAM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 3.19%
GM 50.84%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-41.82%
PM growth 5YN/A
GM growth 3Y-4.74%
GM growth 5Y1.18%
MRAM Yearly Profit, Operating, Gross MarginsMRAM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

8

2. Health

2.1 Basic Checks

MRAM does not have a ROIC to compare to the WACC, probably because it is not profitable.
MRAM has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, MRAM has more shares outstanding
There is no outstanding debt for MRAM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MRAM Yearly Shares OutstandingMRAM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
MRAM Yearly Total Debt VS Total AssetsMRAM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 7.70 indicates that MRAM is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 7.70, MRAM is in the better half of the industry, outperforming 66.96% of the companies in the same industry.
There is no outstanding debt for MRAM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 7.7
ROIC/WACCN/A
WACC11.82%
MRAM Yearly LT Debt VS Equity VS FCFMRAM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

MRAM has a Current Ratio of 5.87. This indicates that MRAM is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 5.87, MRAM belongs to the best of the industry, outperforming 81.25% of the companies in the same industry.
A Quick Ratio of 4.85 indicates that MRAM has no problem at all paying its short term obligations.
The Quick ratio of MRAM (4.85) is better than 81.25% of its industry peers.
Industry RankSector Rank
Current Ratio 5.87
Quick Ratio 4.85
MRAM Yearly Current Assets VS Current LiabilitesMRAM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

5

3. Growth

3.1 Past

MRAM shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.71%.
Measured over the past years, MRAM shows a decrease in Earnings Per Share. The EPS has been decreasing by -4.88% on average per year.
MRAM shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.28%.
MRAM shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.09% yearly.
EPS 1Y (TTM)-3.71%
EPS 3Y-4.88%
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)-11.28%
Revenue growth 3Y-2.96%
Revenue growth 5Y6.09%
Sales Q2Q%24.12%

3.2 Future

The Earnings Per Share is expected to grow by 96.73% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 11.84% on average over the next years. This is quite good.
EPS Next Y-34.5%
EPS Next 2Y4.26%
EPS Next 3Y96.73%
EPS Next 5YN/A
Revenue Next Year10.27%
Revenue Next 2Y11.84%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MRAM Yearly Revenue VS EstimatesMRAM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
MRAM Yearly EPS VS EstimatesMRAM Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 28.97, the valuation of MRAM can be described as expensive.
MRAM's Price/Earnings ratio is a bit cheaper when compared to the industry. MRAM is cheaper than 76.79% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.03, MRAM is valued at the same level.
With a Price/Forward Earnings ratio of 27.71, MRAM can be considered very expensive at the moment.
66.07% of the companies in the same industry are more expensive than MRAM, based on the Price/Forward Earnings ratio.
MRAM's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 22.27.
Industry RankSector Rank
PE 28.97
Fwd PE 27.71
MRAM Price Earnings VS Forward Price EarningsMRAM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

79.46% of the companies in the same industry are more expensive than MRAM, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 30.01
EV/EBITDA N/A
MRAM Per share dataMRAM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

A more expensive valuation may be justified as MRAM's earnings are expected to grow with 96.73% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.26%
EPS Next 3Y96.73%

0

5. Dividend

5.1 Amount

No dividends for MRAM!.
Industry RankSector Rank
Dividend Yield N/A

EVERSPIN TECHNOLOGIES INC

NASDAQ:MRAM (11/4/2025, 8:00:02 PM)

Premarket: 9.85 0 (0%)

9.85

-0.61 (-5.83%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners62.18%
Inst Owner Change-0.61%
Ins Owners5.13%
Ins Owner Change4.8%
Market Cap222.91M
Revenue(TTM)51.67M
Net Income(TTM)1.65M
Analysts82.5
Price Target8.67 (-11.98%)
Short Float %2.5%
Short Ratio2.13
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)612.42%
Min EPS beat(2)17.65%
Max EPS beat(2)1207.19%
EPS beat(4)4
Avg EPS beat(4)770.67%
Min EPS beat(4)17.65%
Max EPS beat(4)1766.67%
EPS beat(8)8
Avg EPS beat(8)402.05%
EPS beat(12)12
Avg EPS beat(12)305.89%
EPS beat(16)16
Avg EPS beat(16)685.42%
Revenue beat(2)1
Avg Revenue beat(2)1.3%
Min Revenue beat(2)-0.44%
Max Revenue beat(2)3.04%
Revenue beat(4)2
Avg Revenue beat(4)1.32%
Min Revenue beat(4)-1.2%
Max Revenue beat(4)3.87%
Revenue beat(8)5
Avg Revenue beat(8)1.01%
Revenue beat(12)9
Avg Revenue beat(12)1.45%
Revenue beat(16)13
Avg Revenue beat(16)3.03%
PT rev (1m)0%
PT rev (3m)-5.56%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)23.53%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.56%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.2%
Valuation
Industry RankSector Rank
PE 28.97
Fwd PE 27.71
P/S 4.31
P/FCF 30.01
P/OCF 16.98
P/B 3.48
P/tB 3.62
EV/EBITDA N/A
EPS(TTM)0.34
EY3.45%
EPS(NY)0.36
Fwd EY3.61%
FCF(TTM)0.33
FCFY3.33%
OCF(TTM)0.58
OCFY5.89%
SpS2.28
BVpS2.83
TBVpS2.72
PEG (NY)N/A
PEG (5Y)N/A
Graham Number4.65
Profitability
Industry RankSector Rank
ROA 2.09%
ROE 2.57%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 3.19%
GM 50.84%
FCFM 14.37%
ROA(3y)8.51%
ROA(5y)2.08%
ROE(3y)11.3%
ROE(5y)0.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-41.82%
PM growth 5YN/A
GM growth 3Y-4.74%
GM growth 5Y1.18%
F-Score4
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 216.61%
Cap/Sales 11.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 450.39%
Current Ratio 5.87
Quick Ratio 4.85
Altman-Z 7.7
F-Score4
WACC11.82%
ROIC/WACCN/A
Cap/Depr(3y)192.66%
Cap/Depr(5y)132.94%
Cap/Sales(3y)4.31%
Cap/Sales(5y)3.11%
Profit Quality(3y)251.99%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.71%
EPS 3Y-4.88%
EPS 5YN/A
EPS Q2Q%200%
EPS Next Y-34.5%
EPS Next 2Y4.26%
EPS Next 3Y96.73%
EPS Next 5YN/A
Revenue 1Y (TTM)-11.28%
Revenue growth 3Y-2.96%
Revenue growth 5Y6.09%
Sales Q2Q%24.12%
Revenue Next Year10.27%
Revenue Next 2Y11.84%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-5211.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1100%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-31.36%
FCF growth 3Y-21.44%
FCF growth 5YN/A
OCF growth 1Y-3.98%
OCF growth 3Y-8.8%
OCF growth 5YN/A

EVERSPIN TECHNOLOGIES INC / MRAM FAQ

Can you provide the ChartMill fundamental rating for EVERSPIN TECHNOLOGIES INC?

ChartMill assigns a fundamental rating of 5 / 10 to MRAM.


Can you provide the valuation status for EVERSPIN TECHNOLOGIES INC?

ChartMill assigns a valuation rating of 3 / 10 to EVERSPIN TECHNOLOGIES INC (MRAM). This can be considered as Overvalued.


Can you provide the profitability details for EVERSPIN TECHNOLOGIES INC?

EVERSPIN TECHNOLOGIES INC (MRAM) has a profitability rating of 3 / 10.


What is the financial health of EVERSPIN TECHNOLOGIES INC (MRAM) stock?

The financial health rating of EVERSPIN TECHNOLOGIES INC (MRAM) is 8 / 10.